메뉴 건너뛰기




Volumn 5, Issue 2, 2014, Pages 85-98

Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases

Author keywords

Aclidinium bromide; Asthma; Chronic obstructive pulmonary disease; Glycopyrronium bromide; Long acting muscarinic receptor antagonists; Tiotropium bromide

Indexed keywords

ACLIDINIUM BROMIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; GLYCOPYRRONIUM BROMIDE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE;

EID: 84898916842     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622313518227     Document Type: Review
Times cited : (70)

References (83)
  • 1
    • 34248204113 scopus 로고    scopus 로고
    • Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma
    • An S. Bai T. Bates J. Black J. Brown R. Brusasco V. et al. (2007) Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 29: 834–860.
    • (2007) Eur Respir J , vol.29 , pp. 834-860
    • An, S.1    Bai, T.2    Bates, J.3    Black, J.4    Brown, R.5    Brusasco, V.6
  • 2
    • 77951962428 scopus 로고    scopus 로고
    • Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice
    • Arai N. Kondo M. Izumo T. Tamaoki J. Nagai A. (2010) Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur Respir J 35: 1164–1171.
    • (2010) Eur Respir J , vol.35 , pp. 1164-1171
    • Arai, N.1    Kondo, M.2    Izumo, T.3    Tamaoki, J.4    Nagai, A.5
  • 3
    • 60249094602 scopus 로고    scopus 로고
    • Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro
    • Asano K. Shikama Y. Shibuya Y. Nakajima H. Kanai K. Yamada N. et al. (2008) Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int J Chron Obstruct Pulmon Dis 3: 781–789.
    • (2008) Int J Chron Obstruct Pulmon Dis , vol.3 , pp. 781-789
    • Asano, K.1    Shikama, Y.2    Shibuya, Y.3    Nakajima, H.4    Kanai, K.5    Yamada, N.6
  • 4
    • 79952056758 scopus 로고    scopus 로고
    • Tiotropium bromide inhibits TGF-beta-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro
    • Asano K. Shikama Y. Shoji N. Hirano K. Suzaki H. Nakajima H. (2010) Tiotropium bromide inhibits TGF-beta-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro. Int J Chron Obstruct Pulmon Dis 5: 277–286.
    • (2010) Int J Chron Obstruct Pulmon Dis , vol.5 , pp. 277-286
    • Asano, K.1    Shikama, Y.2    Shoji, N.3    Hirano, K.4    Suzaki, H.5    Nakajima, H.6
  • 5
    • 79960973276 scopus 로고    scopus 로고
    • Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma
    • Bateman E. Kornmann O. Schmidt P. Pivovarova A. Engel M. Fabbri L. (2011) Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 128: 315–322.
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 315-322
    • Bateman, E.1    Kornmann, O.2    Schmidt, P.3    Pivovarova, A.4    Engel, M.5    Fabbri, L.6
  • 6
    • 27644530096 scopus 로고    scopus 로고
    • Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease
    • discussion 311–312.
    • Belmonte K. (2005) Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 297–304; discussion 311–312.
    • (2005) Proc Am Thorac Soc , vol.2 , pp. 297-304
    • Belmonte, K.1
  • 7
    • 38449113726 scopus 로고    scopus 로고
    • Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
    • Bos I. Gosens R. Zuidhof A. Schaafsma D. Halayko A. Meurs H. et al. (2007) Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30: 653–661.
    • (2007) Eur Respir J , vol.30 , pp. 653-661
    • Bos, I.1    Gosens, R.2    Zuidhof, A.3    Schaafsma, D.4    Halayko, A.5    Meurs, H.6
  • 8
    • 0038366897 scopus 로고    scopus 로고
    • Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol i1n patients with COPD
    • Brusasco V. Hodder R. Miravitlles M. Korducki L. Towse L. Kesten S. (2003) Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol i1n patients with COPD. Thorax 58: 399–404.
    • (2003) Thorax , vol.58 , pp. 399-404
    • Brusasco, V.1    Hodder, R.2    Miravitlles, M.3    Korducki, L.4    Towse, L.5    Kesten, S.6
  • 9
    • 84857089767 scopus 로고    scopus 로고
    • Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea pig model of allergic asthma
    • Buels K. Jacoby D. Fryer A. (2012) Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea pig model of allergic asthma. Br J Pharmacol 165: 1501–1514.
    • (2012) Br J Pharmacol , vol.165 , pp. 1501-1514
    • Buels, K.1    Jacoby, D.2    Fryer, A.3
  • 10
    • 34748819974 scopus 로고    scopus 로고
    • Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro
    • Buhling F. Lieder N. Kuhlmann U. Waldburg N. Welte T. (2007) Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 101: 2386–2394.
    • (2007) Respir Med , vol.101 , pp. 2386-2394
    • Buhling, F.1    Lieder, N.2    Kuhlmann, U.3    Waldburg, N.4    Welte, T.5
  • 11
    • 0036181956 scopus 로고    scopus 로고
    • A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
    • Casaburi R. Mahler D.A. Jones P.W. Wanner A. San P.G. ZuWallack R.L. et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217–224.
    • (2002) Eur Respir J , vol.19 , pp. 217-224
    • Casaburi, R.1    Mahler, D.A.2    Jones, P.W.3    Wanner, A.4    San, P.G.5    ZuWallack, R.L.6
  • 12
    • 0033663165 scopus 로고    scopus 로고
    • MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease
    • Cataldo D. Munaut C. Noel A. Frankenne F. Bartsch P. Foidart J. et al. (2000) MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123: 259–267.
    • (2000) Int Arch Allergy Immunol , vol.123 , pp. 259-267
    • Cataldo, D.1    Munaut, C.2    Noel, A.3    Frankenne, F.4    Bartsch, P.5    Foidart, J.6
  • 14
    • 79953646222 scopus 로고    scopus 로고
    • Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways
    • Cortijo J. Mata M. Milara J. Donet E. Gavalda A. Miralpeix M. et al. (2011) Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways. Eur Respir J 37: 244–254.
    • (2011) Eur Respir J , vol.37 , pp. 244-254
    • Cortijo, J.1    Mata, M.2    Milara, J.3    Donet, E.4    Gavalda, A.5    Miralpeix, M.6
  • 15
    • 78049265848 scopus 로고    scopus 로고
    • Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation
    • Damera G. Jiang M. Zhao H. Fogle H. Jester W. Freire J. et al. (2010) Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. Eur J Pharmacol 649: 349–353.
    • (2010) Eur J Pharmacol , vol.649 , pp. 349-353
    • Damera, G.1    Jiang, M.2    Zhao, H.3    Fogle, H.4    Jester, W.5    Freire, J.6
  • 16
    • 39149107800 scopus 로고    scopus 로고
    • Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice
    • de la Torre E. Genaro A. Ribeiro M. Pagotto R. Pignataro O. Sales M. (2008) Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice. Biochim Biophys Acta 1782: 82–89.
    • (2008) Biochim Biophys Acta , vol.1782 , pp. 82-89
    • de la Torre, E.1    Genaro, A.2    Ribeiro, M.3    Pagotto, R.4    Pignataro, O.5    Sales, M.6
  • 17
    • 84871396857 scopus 로고    scopus 로고
    • Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials
    • Dong Y. Lin H. Shau W. Wu Y. Chang C. Lai M. (2013) Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials. Thorax 68: 48–56.
    • (2013) Thorax , vol.68 , pp. 48-56
    • Dong, Y.1    Lin, H.2    Shau, W.3    Wu, Y.4    Chang, C.5    Lai, M.6
  • 18
    • 82755190518 scopus 로고    scopus 로고
    • Efficacy and safety of once-daily NVA 237 in patients with moderate-to-severe COPD: the GLOW 1 trial
    • D'Urzo A. Ferguson G. van Noord J. Hirata K. Martin C. Horton R. et al. (2011) Efficacy and safety of once-daily NVA 237 in patients with moderate-to-severe COPD: the GLOW 1 trial. Respir Res 12: 156.
    • (2011) Respir Res , vol.12 , pp. 156
    • D'Urzo, A.1    Ferguson, G.2    van Noord, J.3    Hirata, K.4    Martin, C.5    Horton, R.6
  • 19
    • 34247645201 scopus 로고    scopus 로고
    • A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
    • Fardon T. Haggart K. Lee D. Lipworth B. (2007) A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 101: 1218–1228.
    • (2007) Respir Med , vol.101 , pp. 1218-1228
    • Fardon, T.1    Haggart, K.2    Lee, D.3    Lipworth, B.4
  • 20
    • 70350462573 scopus 로고    scopus 로고
    • Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile
    • Gavaldà A. Miralpeix M. Ramos I. Otal R. Carreno C. Vinals M. et al. (2009) Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile. J Pharmacol Exp Ther 331: 740–751.
    • (2009) J Pharmacol Exp Ther , vol.331 , pp. 740-751
    • Gavaldà, A.1    Miralpeix, M.2    Ramos, I.3    Otal, R.4    Carreno, C.5    Vinals, M.6
  • 21
    • 84898864862 scopus 로고    scopus 로고
    • Global Initiative for Asthma (update 2012)
    • GINA Available at
    • GINA (2012) Global Initiative for Asthma (update 2012). Available at: http://www.ginaasthma.org.
    • (2012)
  • 23
    • 18644380685 scopus 로고    scopus 로고
    • Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling
    • Gosens R. Bos I. Zaagsma J. Meurs H. (2005) Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 171: 1096–1102.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 1096-1102
    • Gosens, R.1    Bos, I.2    Zaagsma, J.3    Meurs, H.4
  • 24
    • 73249148900 scopus 로고    scopus 로고
    • Muscarinic M 3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells
    • Gosens R. Rieks D. Meurs H. Ninaber D. Rabe K. Nanninga J. et al. (2009) Muscarinic M 3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J 34: 1436–1443.
    • (2009) Eur Respir J , vol.34 , pp. 1436-1443
    • Gosens, R.1    Rieks, D.2    Meurs, H.3    Ninaber, D.4    Rabe, K.5    Nanninga, J.6
  • 25
    • 33745218112 scopus 로고    scopus 로고
    • Muscarinic receptor signaling in the pathophysiology of asthma and COPD
    • Gosens R. Zaagsma J. Meurs H. Halayko A. (2006) Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7: 73.
    • (2006) Respir Res , vol.7 , pp. 73
    • Gosens, R.1    Zaagsma, J.2    Meurs, H.3    Halayko, A.4
  • 26
    • 58149376396 scopus 로고    scopus 로고
    • Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
    • Haag S. Matthiesen S. Juergens U. Racke K. (2008) Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J 32: 555–562.
    • (2008) Eur Respir J , vol.32 , pp. 555-562
    • Haag, S.1    Matthiesen, S.2    Juergens, U.3    Racke, K.4
  • 27
    • 66549116089 scopus 로고    scopus 로고
    • Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations
    • Halpin D. Menjoge S. Viel K. (2009) Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations. Prim Care Respir J 18: 106–113.
    • (2009) Prim Care Respir J , vol.18 , pp. 106-113
    • Halpin, D.1    Menjoge, S.2    Viel, K.3
  • 28
    • 2942720573 scopus 로고    scopus 로고
    • The nature of small-airway obstruction in chronic obstructive pulmonary disease
    • Hogg J. Chu F. Utokaparch S. Woods R. Elliott W. Buzatu L. et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645–2653.
    • (2004) N Engl J Med , vol.350 , pp. 2645-2653
    • Hogg, J.1    Chu, F.2    Utokaparch, S.3    Woods, R.4    Elliott, W.5    Buzatu, L.6
  • 29
    • 0035077465 scopus 로고    scopus 로고
    • Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema
    • Imai K. Dalal S. Chen E. Downey R. Schulman L. Ginsburg M. et al. (2001) Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163: 786–791.
    • (2001) Am J Respir Crit Care Med , vol.163 , pp. 786-791
    • Imai, K.1    Dalal, S.2    Chen, E.3    Downey, R.4    Schulman, L.5    Ginsburg, M.6
  • 30
    • 0026506533 scopus 로고
    • Muscarinic receptor subtypes in feline tracheal submucosal gland secretion
    • Ishihara H. Shimura S. Satoh M. Masuda T. Nonaka H. Kase H. et al. (1992) Muscarinic receptor subtypes in feline tracheal submucosal gland secretion. Am J Physiol 262: L223–L228.
    • (1992) Am J Physiol , vol.262 , pp. L223-L228
    • Ishihara, H.1    Shimura, S.2    Satoh, M.3    Masuda, T.4    Nonaka, H.5    Kase, H.6
  • 31
    • 0027232088 scopus 로고
    • Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M 2 receptor
    • Jacoby D. Gleich G. Fryer A. (1993) Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M 2 receptor. J Clin Invest 91: 1314–1318.
    • (1993) J Clin Invest , vol.91 , pp. 1314-1318
    • Jacoby, D.1    Gleich, G.2    Fryer, A.3
  • 32
    • 70349146860 scopus 로고    scopus 로고
    • Airway smooth muscle thickness in asthma is related to severity but not duration of asthma
    • James A. Bai T. Mauad T. Abramson M. Dolhnikoff M. McKay K. et al. (2009) Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J 34: 1040–1045.
    • (2009) Eur Respir J , vol.34 , pp. 1040-1045
    • James, A.1    Bai, T.2    Mauad, T.3    Abramson, M.4    Dolhnikoff, M.5    McKay, K.6
  • 33
    • 70349513461 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants
    • Jansat J. Lamarca R. de Miquel G. Schrodter A. Miletzki B. Gurniak M. (2009) Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants. J Clin Pharmacol 49: 1239–1246.
    • (2009) J Clin Pharmacol , vol.49 , pp. 1239-1246
    • Jansat, J.1    Lamarca, R.2    de Miquel, G.3    Schrodter, A.4    Miletzki, B.5    Gurniak, M.6
  • 34
    • 0035891664 scopus 로고    scopus 로고
    • Remodeling in asthma and chronic obstructive lung disease
    • Jeffery P. (2001) Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164: S28–S38.
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. S28-S38
    • Jeffery, P.1
  • 35
    • 79955091292 scopus 로고    scopus 로고
    • Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
    • Jones P. Rennard S. Agusti A. Chanez P. Magnussen H. Fabbri L. et al. (2011) Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease. Respir Res 12: 55.
    • (2011) Respir Res , vol.12 , pp. 55
    • Jones, P.1    Rennard, S.2    Agusti, A.3    Chanez, P.4    Magnussen, H.5    Fabbri, L.6
  • 36
    • 77952289988 scopus 로고    scopus 로고
    • Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients
    • Joos G. Schelfhout V. Pauwels R. Kanniess F. Magnussen H. Lamarca R. et al. (2010) Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients. Respir Med 104: 865–872.
    • (2010) Respir Med , vol.104 , pp. 865-872
    • Joos, G.1    Schelfhout, V.2    Pauwels, R.3    Kanniess, F.4    Magnussen, H.5    Lamarca, R.6
  • 37
    • 84866439937 scopus 로고    scopus 로고
    • Tiotropium versus placebo for chronic obstructive pulmonary disease
    • CD009285.
    • Karner C. Chong J. Poole P. (2012) Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 7: CD009285.
    • (2012) Cochrane Database Syst Rev , vol.7
    • Karner, C.1    Chong, J.2    Poole, P.3
  • 38
    • 33645679788 scopus 로고    scopus 로고
    • Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM
    • Kanefsky J. Lenburg M. Hai C. (2006) Cholinergic receptor and cyclic stretch-mediated inflammatory gene expression in intact ASM. Am J Respir Cell Mol Biol 34: 417–425.
    • (2006) Am J Respir Cell Mol Biol , vol.34 , pp. 417-425
    • Kanefsky, J.1    Lenburg, M.2    Hai, C.3
  • 39
    • 0037212314 scopus 로고    scopus 로고
    • Role of matrix metalloproteinases in asthma
    • Kelly E. Jarjour N. (2003) Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 9: 28–33.
    • (2003) Curr Opin Pulm Med , vol.9 , pp. 28-33
    • Kelly, E.1    Jarjour, N.2
  • 40
    • 79961016525 scopus 로고    scopus 로고
    • Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial
    • Kerstjens H. Disse B. Schröder-Babo W. Bantje T. Gahlemann M. Sigmund R. et al. (2011) Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 128: 308–314.
    • (2011) J Allergy Clin Immunol , vol.128 , pp. 308-314
    • Kerstjens, H.1    Disse, B.2    Schröder-Babo, W.3    Bantje, T.4    Gahlemann, M.5    Sigmund, R.6
  • 41
  • 42
    • 84859305834 scopus 로고    scopus 로고
    • for the ACCORD I study investigators
    • Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I)
    • Kerwin E. D'Urzo A. Gelb A. Lakkis H. Garcia Gil E. Caracta C., for the ACCORD I study investigators (2012 a) Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD 9: 90–101.
    • (2012) COPD , vol.9 , pp. 90-101
    • Kerwin, E.1    D'Urzo, A.2    Gelb, A.3    Lakkis, H.4    Garcia Gil, E.5    Caracta, C.6
  • 43
    • 84868554172 scopus 로고    scopus 로고
    • Efficacy and safety of NVA 237 versus placebo and tiotropium in patients with moderate-to-severe COPD over 52 weeks: The GLOW 2 study
    • Kerwin E. Hebert J. Gallagher N. Martin C. Overend T. Alagappan V.K. et al. (2012 b) Efficacy and safety of NVA 237 versus placebo and tiotropium in patients with moderate-to-severe COPD over 52 weeks: The GLOW 2 study. Eur Respir J 40: 1106–1114.
    • (2012) Eur Respir J , vol.40 , pp. 1106-1114
    • Kerwin, E.1    Hebert, J.2    Gallagher, N.3    Martin, C.4    Overend, T.5    Alagappan, V.K.6
  • 44
    • 84872826158 scopus 로고    scopus 로고
    • Regulation of airway inflammation and remodeling by muscarinic receptors: Perspectives on anticholinergic therapy in asthma and COPD
    • Kistemaker L. Oenema T. Meurs H. Gosens R. (2012) Regulation of airway inflammation and remodeling by muscarinic receptors: Perspectives on anticholinergic therapy in asthma and COPD. Life Sci 91: 1126–1133.
    • (2012) Life Sci , vol.91 , pp. 1126-1133
    • Kistemaker, L.1    Oenema, T.2    Meurs, H.3    Gosens, R.4
  • 45
    • 0026697298 scopus 로고
    • Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity
    • Koyama S. Rennard S. Robbins R. (1992) Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 262: L466–L471.
    • (1992) Am J Physiol , vol.262 , pp. L466-L471
    • Koyama, S.1    Rennard, S.2    Robbins, R.3
  • 46
    • 0031957332 scopus 로고    scopus 로고
    • Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity
    • Koyama S. Sato E. Nomura H. Kubo K. Nagai S. Izumi T. (1998) Acetylcholine and substance P stimulate bronchial epithelial cells to release eosinophil chemotactic activity. J Appl Physiol 84: 1528–1534.
    • (1998) J Appl Physiol , vol.84 , pp. 1528-1534
    • Koyama, S.1    Sato, E.2    Nomura, H.3    Kubo, K.4    Nagai, S.5    Izumi, T.6
  • 47
    • 77649272395 scopus 로고    scopus 로고
    • Role of matrix metalloproteinases in the inflammatory process of respiratory diseases
    • Lagente V. Boichot E. (2010) Role of matrix metalloproteinases in the inflammatory process of respiratory diseases. J Mol Cell Cardiol 48: 440–444.
    • (2010) J Mol Cell Cardiol , vol.48 , pp. 440-444
    • Lagente, V.1    Boichot, E.2
  • 48
    • 79955838243 scopus 로고    scopus 로고
    • Aclidinium bromide, a long- acting antimuscarinic, does not affect QT interval in healthy subjects
    • Lasseter K. Aubets J. Chuecos F. Gil E. (2011) Aclidinium bromide, a long- acting antimuscarinic, does not affect QT interval in healthy subjects. J Clin Pharmacol 51: 923–932.
    • (2011) J Clin Pharmacol , vol.51 , pp. 923-932
    • Lasseter, K.1    Aubets, J.2    Chuecos, F.3    Gil, E.4
  • 50
    • 79952279994 scopus 로고    scopus 로고
    • Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD
    • Maltais F. Celli B. Casaburi R. Porszasz J. Jarreta D. Seoane B. et al. (2011) Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med 105: 580–587.
    • (2011) Respir Med , vol.105 , pp. 580-587
    • Maltais, F.1    Celli, B.2    Casaburi, R.3    Porszasz, J.4    Jarreta, D.5    Seoane, B.6
  • 52
    • 84878802677 scopus 로고    scopus 로고
    • Aclidinium inhibits cigarette smoke-induced lung fibroblast to myofibroblast transition
    • Milara J. Serrano A. Peiró T. Artigues E. Gavaldà A. Miralpeix M. et al. (2013) Aclidinium inhibits cigarette smoke-induced lung fibroblast to myofibroblast transition. Eur Respir J 41: 1264–1274.
    • (2013) Eur Respir J , vol.41 , pp. 1264-1274
    • Milara, J.1    Serrano, A.2    Peiró, T.3    Artigues, E.4    Gavaldà, A.5    Miralpeix, M.6
  • 55
    • 77954357471 scopus 로고    scopus 로고
    • Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma
    • Ohta S. Oda N. Yokoe T. Tanaka A. Yamamoto Y. Watanabe Y. et al. (2010) Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 40: 1266–1275.
    • (2010) Clin Exp Allergy , vol.40 , pp. 1266-1275
    • Ohta, S.1    Oda, N.2    Yokoe, T.3    Tanaka, A.4    Yamamoto, Y.5    Watanabe, Y.6
  • 56
    • 0031417650 scopus 로고    scopus 로고
    • The functional consequences of airway remodeling in asthma
    • Pare P. Roberts C. Bai T. Wiggs B. (1997) The functional consequences of airway remodeling in asthma. Monaldi Arch Chest Dis 52: 589–596.
    • (1997) Monaldi Arch Chest Dis , vol.52 , pp. 589-596
    • Pare, P.1    Roberts, C.2    Bai, T.3    Wiggs, B.4
  • 57
    • 63849193838 scopus 로고    scopus 로고
    • Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB 2 as a potential marker to predict response
    • Park H. Yang M. Park C. Kim T. Moon H. Min K. et al. (2009) Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB 2 as a potential marker to predict response. Allergy 64: 778–783.
    • (2009) Allergy , vol.64 , pp. 778-783
    • Park, H.1    Yang, M.2    Park, C.3    Kim, T.4    Moon, H.5    Min, K.6
  • 58
    • 80052940501 scopus 로고    scopus 로고
    • Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD
    • Pera T. Zuidhof A. Valadas J. Smit M. Schoemaker R. Gosens R. et al. (2011) Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J 38: 789–796.
    • (2011) Eur Respir J , vol.38 , pp. 789-796
    • Pera, T.1    Zuidhof, A.2    Valadas, J.3    Smit, M.4    Schoemaker, R.5    Gosens, R.6
  • 60
    • 69049103119 scopus 로고    scopus 로고
    • Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl) acetyl] oxy}-1-(3-phenoxypropyl)-1- azoniabicy clo [2.2.2] octane bromide (aclidinium bromide)
    • Prat M. Fernandez D. Buil M. Crespo M.I. Casals G. Ferrer M. et al. (2009) Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl] oxy}-1-(3-phenoxypropyl)-1- azoniabicy clo [2.2.2] octane bromide (aclidinium bromide). J Med Chem 52: 5076–5092.
    • (2009) J Med Chem , vol.52 , pp. 5076-5092
    • Prat, M.1    Fernandez, D.2    Buil, M.3    Crespo, M.I.4    Casals, G.5    Ferrer, M.6
  • 61
    • 79959346315 scopus 로고    scopus 로고
    • Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro
    • Profita M. Bonanno A. Montalbano A. Ferraro M. Siena L. Bruno A. et al. (2011) Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sci 89: 36–43.
    • (2011) Life Sci , vol.89 , pp. 36-43
    • Profita, M.1    Bonanno, A.2    Montalbano, A.3    Ferraro, M.4    Siena, L.5    Bruno, A.6
  • 62
    • 39149132101 scopus 로고    scopus 로고
    • Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK- dependent mechanism
    • Profita M. Bonanno A. Siena L. Ferraro M. Montalbano A. Pompeo F. et al. (2008) Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK- dependent mechanism. Eur J Pharmacol 582: 145–153.
    • (2008) Eur J Pharmacol , vol.582 , pp. 145-153
    • Profita, M.1    Bonanno, A.2    Siena, L.3    Ferraro, M.4    Montalbano, A.5    Pompeo, F.6
  • 63
    • 26944437890 scopus 로고    scopus 로고
    • Muscarinic receptors, leukotriene B 4 production and neutrophilic inflammation in COPD patients
    • Profita M. Giorgi R. Sala A. Bonanno A. Riccobono L. Mirabella F. et al. (2005) Muscarinic receptors, leukotriene B 4 production and neutrophilic inflammation in COPD patients. Allergy 60: 1361–1369.
    • (2005) Allergy , vol.60 , pp. 1361-1369
    • Profita, M.1    Giorgi, R.2    Sala, A.3    Bonanno, A.4    Riccobono, L.5    Mirabella, F.6
  • 64
    • 2042443069 scopus 로고    scopus 로고
    • Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells
    • Proskocil B. Sekhon H. Jia Y. Savchenko V. Blakely R. Lindstrom J. et al. (2004) Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 145: 2498–2506.
    • (2004) Endocrinology , vol.145 , pp. 2498-2506
    • Proskocil, B.1    Sekhon, H.2    Jia, Y.3    Savchenko, V.4    Blakely, R.5    Lindstrom, J.6
  • 65
    • 0029793984 scopus 로고    scopus 로고
    • On muscarinic control of neurogenic mucus secretion in ferret trachea
    • Ramnarine S. Haddad E. Khawaja A. Mak J. Rogers D. (1996) On muscarinic control of neurogenic mucus secretion in ferret trachea. J Physiol 494: 577–586.
    • (1996) J Physiol , vol.494 , pp. 577-586
    • Ramnarine, S.1    Haddad, E.2    Khawaja, A.3    Mak, J.4    Rogers, D.5
  • 67
    • 0035126934 scopus 로고    scopus 로고
    • Motor control of airway goblet cells and glands
    • Rogers D. (2001) Motor control of airway goblet cells and glands. Respir Physiol 125: 129–144.
    • (2001) Respir Physiol , vol.125 , pp. 129-144
    • Rogers, D.1
  • 68
    • 0031778288 scopus 로고    scopus 로고
    • Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity
    • Sato E. Koyama S. Okubo Y. Kubo K. Sekiguchi M. (1998) Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 274: L970–L979.
    • (1998) Am J Physiol , vol.274 , pp. L970-L979
    • Sato, E.1    Koyama, S.2    Okubo, Y.3    Kubo, K.4    Sekiguchi, M.5
  • 69
    • 77950675030 scopus 로고    scopus 로고
    • Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study
    • Schelfhout V. Ferrer P. Jansat J. Peris F. Gil E.G. Pauwels R.A. et al. (2010) Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study. Br J Clin Pharmacol 69: 458–464.
    • (2010) Br J Clin Pharmacol , vol.69 , pp. 458-464
    • Schelfhout, V.1    Ferrer, P.2    Jansat, J.3    Peris, F.4    Gil, E.G.5    Pauwels, R.A.6
  • 70
    • 77549086503 scopus 로고    scopus 로고
    • Aclidinium bromide, a new, long- acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites
    • Sentellas S. Ramos I. Alberti J. Salvà M. Antón F. Miralpeix M. et al. (2010) Aclidinium bromide, a new, long- acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites. Eur J Pharm Sci 39: 283–290.
    • (2010) Eur J Pharm Sci , vol.39 , pp. 283-290
    • Sentellas, S.1    Ramos, I.2    Alberti, J.3    Salvà, M.4    Antón, F.5    Miralpeix, M.6
  • 71
    • 84859008802 scopus 로고    scopus 로고
    • Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials
    • Singh S. Loke Y. Enright P. Furberg C. (2011) Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ 342: d3215.
    • (2011) BMJ , vol.342 , pp. d3215
    • Singh, S.1    Loke, Y.2    Enright, P.3    Furberg, C.4
  • 72
    • 77951134764 scopus 로고    scopus 로고
    • Remodeling in asthma and COPD - differences and similarities
    • Sköld C. (2010) Remodeling in asthma and COPD - differences and similarities. Clin Respir J 4(Suppl. 1): 20–27.
    • (2010) Clin Respir J , vol.4 , pp. 20-27
    • Sköld, C.1
  • 73
    • 69549098265 scopus 로고    scopus 로고
    • Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M 3 receptor
    • Sykes D. Dowling M. Charlton S. (2009) Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M 3 receptor. Mol Pharmacol 76: 543–551.
    • (2009) Mol Pharmacol , vol.76 , pp. 543-551
    • Sykes, D.1    Dowling, M.2    Charlton, S.3
  • 74
    • 53749102775 scopus 로고    scopus 로고
    • for the UPLIFT Study Investigators
    • A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    • Tashkin D. Celli B. Senn S. Burkhart D. Kesten S. Menjoge S. et al. for the UPLIFT Study Investigators (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 1543–1554.
    • (2008) N Engl J Med , vol.359 , pp. 1543-1554
    • Tashkin, D.1    Celli, B.2    Senn, S.3    Burkhart, D.4    Kesten, S.5    Menjoge, S.6
  • 75
    • 84872231976 scopus 로고    scopus 로고
    • Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit
    • Ulrik C. (2012) Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit. Int J COPD 7: 673–678.
    • (2012) Int J COPD , vol.7 , pp. 673-678
    • Ulrik, C.1
  • 76
    • 79951951764 scopus 로고    scopus 로고
    • Inhibition of granulocyte migration by tiotropium bromide
    • Vacca G. Randerath W. Gillissen A. (2011) Inhibition of granulocyte migration by tiotropium bromide. Respir Res 12: 24.
    • (2011) Respir Res , vol.12 , pp. 24
    • Vacca, G.1    Randerath, W.2    Gillissen, A.3
  • 77
    • 77956957659 scopus 로고    scopus 로고
    • Onset of effect of aclidinium, a novel long-acting muscarinic antagonist, in patients with COPD
    • Vestbo J. Vogelmeier C. Creemers J. Faiques M. Ribera A. Gil E. (2010) Onset of effect of aclidinium, a novel long-acting muscarinic antagonist, in patients with COPD. COPD 7: 331–336.
    • (2010) COPD , vol.7 , pp. 331-336
    • Vestbo, J.1    Vogelmeier, C.2    Creemers, J.3    Faiques, M.4    Ribera, A.5    Gil, E.6
  • 78
    • 79957802503 scopus 로고    scopus 로고
    • NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease
    • Vogelmeier C. Banerji D. (2011) NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease. Ther Adv Respir Dis 5: 163–173.
    • (2011) Ther Adv Respir Dis , vol.5 , pp. 163-173
    • Vogelmeier, C.1    Banerji, D.2
  • 79
    • 60249095813 scopus 로고    scopus 로고
    • Mucins, mucus, and sputum
    • Voynow J. Rubin B. (2009) Mucins, mucus, and sputum. Chest 135: 505–512.
    • (2009) Chest , vol.135 , pp. 505-512
    • Voynow, J.1    Rubin, B.2
  • 80
    • 49449094458 scopus 로고    scopus 로고
    • Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans
    • Wessler I. Kirkpatrick C. (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154: 1558–1571.
    • (2008) Br J Pharmacol , vol.154 , pp. 1558-1571
    • Wessler, I.1    Kirkpatrick, C.2
  • 81
    • 84885734407 scopus 로고    scopus 로고
    • for the TIOSPIR Investigators
    • Tiotropium Respimat inhaler and the risk of death in COPD
    • Wise R. Anzueto A. Cotton D. Dahl R. Devins T. Disse B. et al. for the TIOSPIR Investigators (2013) Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med 369: 1491–1501.
    • (2013) N Engl J Med , vol.369 , pp. 1491-1501
    • Wise, R.1    Anzueto, A.2    Cotton, D.3    Dahl, R.4    Devins, T.5    Disse, B.6
  • 82
    • 77953123408 scopus 로고    scopus 로고
    • Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD
    • Wollin L. Pieper M. (2010) Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther 23: 345–354.
    • (2010) Pulm Pharmacol Ther , vol.23 , pp. 345-354
    • Wollin, L.1    Pieper, M.2
  • 83
    • 79955664791 scopus 로고    scopus 로고
    • Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes
    • Yohannes A. Willgoss T. Vestbo J. (2011) Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care 56: 477–487.
    • (2011) Respir Care , vol.56 , pp. 477-487
    • Yohannes, A.1    Willgoss, T.2    Vestbo, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.